Focus Areas

Women’s Global Health Imperative (WGHI)

Conducting rigorous epidemiologic, biomedical, socio-behavioral and implementation research to improve infectious disease and chronic health outcomes

Research conducted by RTI's Women's Global Health Imperative (WGHI) informs the design, implementation and scale-up of new programs, monitoring and evaluation systems, and health policies around the world—particularly as they pertain to addressing health inequities. Our areas of expertise include: 

  • Biomedical prevention strategies
  • Socio-behavioral acceptability and adherence research on novel HIV prevention products
  • Mixed-methods, community-engaged research
  • The intersection of violence, education, and economic opportunities on adolescent health
  • Implementation, scale-up, and improvement of health services delivery
  • Increasing engagement in HIV services among key and hard-to-reach populations
  • The effects of poverty and gender-based violence on women’s health over the lifecycle

Long-Acting HIV Prevention Drug Takes a Step Toward Federal Regulation – a Milestone in HIV Prevention

The European Medicines Agency announced today a favorable scientific opinion about the monthly dapivirine vaginal ring (DPV) for HIV prevention. This is the first long-acting, safe and effective, HIV prevention product of its kind for women and further secures the DPV ring on a trajectory towards regulatory approval, globally. 

Learn More

WGHI's Global Network

Women's Global Health Imperative

Women’s Global Health Imperative works with many collaborators around the world. These long-held and continuing relationships have greatly enriched their work and research.

The epidemiologists and biomedical and behavioral scientists at WGHI have developed an international reputation as experts in women’s health and global health. WGHI is affiliated with the School of Medicine at the University of California, San Francisco, and the School of Public Health at the University of California, Berkeley, where our investigators serve as faculty members. We also have more than 20 research partners at academic, research and nonprofit organizations across Africa, Asia, Europe, and North America.

TRIO Study Briefs

Preventing HIV in Sub-Saharan Africa

What end-users think about HIV prevention products and multipurpose prevention technologies (MPT)

View Downloadable Brief

Preventing HIV in Sub-Saharan Africa

Listening to young women in Kenya and South Africa to inform multipurpose “2-in-1” products for HIV and pregnancy prevention

View Downloadable Brief

Partner with Us

We are looking forward to hearing about your project and identifying how our team of experts can help!

Contact Us

Funding Resources

The Women’s Global Health Imperative and its research programs are funded by a broad range of sources, including the United States Agency for International Development, the Bill & Melinda Gates Foundation, the Centers for Disease Control and Prevention, World Bank, UNICEF, the Wellspring Foundation, and multiple institutes and centers of the U.S. National Institutes of Health (NIH). NIH funding includes the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Mental Health, and the Office of Behavioral and Social Science Research. 

The contents of this site are the responsibility of RTI International and do not necessarily reflect the views of USAID, the NIH, or the United States Government.

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: Click “accept” to agree.